ANALISIS BIAYA KEMOTERAPI PASIEN KANKER PAYUDARA DAN KANKER SERVIKS DI RSUD ULIN BANJARMASIN

  • Noor Aisyah Akademi Farmasi ISFI Banjarmasin
  • Akhmad Syarifuddin Akademi Farmasi ISFI Banjarmasin
  • Putri Amami Akademi Farmasi ISFI Banjarmasin
  • Mardiana Mardiana RSUD Ulin Banjarmasin
Keywords: Cost, Breast Cancer, Cervical Cancer

Abstract

Breast cancer and cervical cancer are the most cancers in Indonesia that require public health action and intervention.Cancer financing at Jamkesmas 2012 ranked second as much Rp.144.7M.The aim of the study was to find out the comparison between the real costs and the INA-CBGs package rates for breast cancer chemotherapy patients and cervical cancer JKN participants in RSUD Ulin Banjarmain.Nonexperimental research method with cross-sectional data design was taken retrospectively from JKN claim file in 2018, the study is comparative.Research samples in cancer patients were 306 episodes of care and 127 episodes of care in cervical cancer patients.Data analysis was tested with one-sample t-test to see the comparison of average real costs with INA CBG rates.Based on the results of one-sample t-test, it shows that in all severity levels(I,II,III) there is a significant difference (p<0.05) between real costs and INA-CBGs package rates, except for the severity of I (class1) values p>0.05. The average cost for breast cancer patients to pay for each chemotherapy, the severity I is Rp.4,496,831 and the severity II is Rp.7,797,032.The average cost in patients with cervical cancer chemotherapy, at the severity level I Rp.3,388,248, the severity level II Rp.3,475,007 and the severity level III Rp.3,535,933.

References

Aisyah N, Andayani T.M, Puspandari D.A, 2018, Analisis Biaya Kemoterapi Pada Pasien Rawat Inap Kanker Payudara Peserta JKN di RSUD Ulin Banjarmasin, Jurnal Ilmiah Ibnu Sina, Vol 3 No.2,hal 333-342

Globocan (2013). Latest world cancer statistics Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breastcancers must be addressed. International Agency for Research on Cancer.https://www.iarc.fr/wpcontent/uploads/2018/07/pr223_E.pdf

Hartati, N., Andrijono., Suheimi, H.K., 2010, Cegah Dan Deteksi Kanker Serviks, Elex Media Komputindo, Jakarta, Indonesia.

Kementerian Kesehatan RI, 2013, Laporan Nasional Riset Kesehatan Dasar 2013, Badan Penelitian dan Pengembangan Kesehatan, Jakarta

Kementerian Kesehatan RI, 2015a, Program Nasional Gerakan Pencegahan Dan Deteksi Dini Kanker Kanker Leher Rahim Dan Kanker Payudara, Jakarta, Kementerian Kesehatan Republik Indonesia.

Kementerian Kesehatan RI, 2015b, Peraturan Kementerian Kesehatan No.34 tentang Penanggulangan Kanker Payudara Dan Kanker Leher Rahim, Jakarta, Kementerian Kesehatan Republik Indonesia.

Kementerian Kesehatan, 2017, Tentang Pedoman Nasional Pelayanan Kedokteran Kanker Paru, Jakarta, Kementerian Kesehatan Republik Indonesia.

Kementerian Kesehatan RI, 2018, Laporan Nasional Riset Kesehatan Dasar 2018, Badan Penelitian dan Pengembangan Kesehatan, Jakarta

Oktaviani, D. 2012, ‘Analisis biaya pengobatan kanker serviks sebagai pertimbangan dalam penetapan pembiayaan kesehatan berdasarkan INA-DRG’s di RSUD Dr. Moewardi’, Journal of Management and Pharmacy Practice, Vol 2 No.1 : 38-44

Puspandari, D.A., Mukti, A.G., dan Kusnanto, H., 2015. Faktor-Faktor yang Mempengaruhi Biaya Obat Pasien Kanker Payudara di Rumah Sakit di Indonesia . Jurnal Kebijakan Kesehatan Indonesia, 04: 104–108. https://journal.ugm.ac.id/jkki/article/view/361 10

Wintarani, N.P., Suwantara, P.T., Shantini S, N.M.D., 2017, Analisis Kesesuaian Biaya Riil Pasien Kemoterapi Kanker Serviks Dengan Tarif Paket INA-CBG’s Pada Pasien JKN Rawat Inap Di RSUP Sanglah Denpasar Tahun 2014, Medicamento, Vol.3 No.1 : 53-60.

Published
2020-05-30
How to Cite
1.
Aisyah N, Syarifuddin A, Amami P, Mardiana M. ANALISIS BIAYA KEMOTERAPI PASIEN KANKER PAYUDARA DAN KANKER SERVIKS DI RSUD ULIN BANJARMASIN. JIFI [Internet]. 30May2020 [cited 27Sep.2020];3(1):19 -28. Available from: http://jiis.akfar-isfibjm.ac.id/index.php?journal=JIFI&page=article&op=view&path[]=500